Mulmit

GYRE THERAPEUTICS, INC.GYRE THERAPEUTICS, INC.

GYRE Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31116,588,00011,487,0009,880,0000.02
2024-12-31105,757,00016,163,00017,898,0000.05
2023-12-31113,450,000-67,230,000-85,480,000-1.41
2022-12-31102,290,0009,203,0004,314,0000.03
2021-12-317,338,000-87,894,000-87,933,000-2.87

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-03Weston Claire40,000
2026-08-03Kirkby Maxwell40,000
2026-06-18Ye WeiguoChief Operating Officer3,000
2026-06-18Ye WeiguoChief Operating Officer3,000
2026-06-18Ye WeiguoChief Operating Officer3,000
2026-06-11Ye WeiguoChief Operating Officer2,800
2026-06-11Ye WeiguoChief Operating Officer2,800
2026-06-11Ye WeiguoChief Operating Officer2,800
2026-06-10Carmichael Gordon40,000
2026-06-10Epstein David M.40,000
2026-06-10Weng Dan40,000
2026-06-10Parry Renate40,000

8-K events

FiledItems
2026-09-01Regulation FD disclosure · Financial statements and exhibits
2026-08-26Regulation FD disclosure · Financial statements and exhibits
2026-08-07Results of operations · Financial statements and exhibits
2026-07-16Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-07-15Results of operations · Financial statements and exhibits
2026-06-16Submission of matters to a vote
2026-06-02Regulation FD disclosure · Financial statements and exhibits
2026-05-14Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.